Adherence to the ketogenic diet |
99 MS subjects |
Amelioration of fatigue and depression accompanied by weight loss and reduction in pro-inflammatory cytokines |
[136] |
Adherence to the OMS diet |
Data from an international population of MS followed over 7.5 years |
Lower depression rate |
[140] |
High intake of grain or meat, fat, and milk from animals (elevate content of phytic acid) |
75 MS women and 75 healthy controls |
Positive correlation with the prevalence of MS |
[166] |
Omega-3 fatty acid and fish oils supplementation |
Systematic review of 5554 studies |
Beneficial effects on reducing relapsing rate, inflammatory markers, and improving quality of life |
[142] |
Diets enriched in PUFAs |
80,920 women from Nurses’ Health Study and 94,511 women from Nurses’ Health Study II |
Lower incidence of MS. Among the specific types of PUFA, only α-linolenic acid was inversely associated with MS risk |
[144] |
Omega-3 PUFAs supplementation |
10 MS patients |
Improvement in quality of life by decreasing relapse rates |
[148] |
Vitamin D deficiency |
92,253 women from the Nurses’ Health Study (NHS) and 95,310 women from the Nurses’ Health Study II (NHS II) |
Higher risk of MS incidence |
[155] |
Low vitamin D intake |
Review of literature data |
Increased incidence of MS, but the risk–benefit profile of dosage and duration or supplementation needs to be clarified |
[156] |
Vitamin D supplementation |
172 MS patients were randomized: low-dose vitamin D3–high-dose vitamin D3 |
Lack of significant effects |
[157] |
Low levels of vitamin A |
31 MS patients and 29 matched controls |
Lack of correlation with the incidence of MS |
[159] |
Vitamin A supplementation |
101 MS patients in a placebo randomized clinical trial |
Significant improvement in fatigue and depression. Improvement also in psychiatric outcomes during interferon therapy |
[160] |
Probiotics supplementation |
40 MS patients |
Significant improvement in inflammatory markers, oxidative stress indicators, pain, fatigue, and quality of life |
[171] |
Probiotics supplementation |
60 MS patients |
Significant improvements in disability scores and mental health parameters, such as reduced depressive symptoms, anxiety, and stress |
[172] |